Biomedtech News

Philippe Pouletty and Hartmut J. Ehrlich - ABIVAX - Covid-19 Quarantine

June 2, 2020

-The Corporate COVID Quarantine

-Was this Meeting Really Necessary?

-Anti-Viral Data Icing on The Cake

ALSO TO BE DISCOVERED

https_blogs_images.forbes.com_genemarcial_files_2020_05_covid_300x158.jpg

https_blogs_images.forbes.com_genemarcial_files_2020_05_covid_300x158.jpg

May 21, 2020

Investors Search for Promising Covid Cures

May 18, 2020

€ 36M non-dilutive funding from Bpifrance for ABIVAX’ ABX464 Covid-19 program

May 14, 2020

Abivax Stock Soars as French Regulator Approves Testing of a Drug to Treat Covid-19

May 14, 2020

Abivax to evaluate anti-inflammatory effects of ABX464 in large-scale COVID-19 trial

May 14, 2020

Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 Patients in randomized Phase 2B/3 clinical trial

March 3, 2020

Bloomberg : Diaccurate Scientists show how HIV disables Immune System

February 27, 2020

Abivax Includes First Patient in U.S. Phase 1/2 Clinical Trial of ABX196 to Treat Hepatocellular Carcinoma

December 19, 2019

Truffle Capital Raises € 250m Fund to Launch Life Science Startups

December 3, 2019

Affluent Medical announces first patient implanted in optimise II pivotal clinical study for Kalios, the minimally invasive mitral valve repair ring

December 3, 2019

Carbios receives € 1.4M from ADEME following the success of the first milestone of its CE-PET research project